Event Abstract

A pre-validation trial - testing genotoxicity of several chemicals using standard, medium- and high-throughput comet formats.

  • 1 Norwegian institute of public health, Environmental medicine, Norway
  • 2 University of Navarra, Department of Pharmacology and Toxicology, Spain
  • 3 Safety Assessment, AstraZeneca R&D, United Kingdom
  • 4 Slovak Medical University in Bratislava, Slovakia
  • 5 Norwegian Institute for Air Research, Department of Environmental Chemistry, Norway
  • 6 IMSTAR SA, France
  • 7 University of Oslo, Department of Nutrition, Faculty of Medicine, Norway

As part of the EU-project COMICS, high throughput versions of the comet assay was developed. In order to test the performance of the new formats; the novel 12-gel slide and the 96-minigel film were compared with standard 3-gel slides for their ability to detect effects of genotoxic chemicals on cellular DNA with limited cytotoxicity. Among the chemicals were negative controls, a non-carcinogen that causes DNA damage through cytotoxicity, and carcinogens that are known to be hard to detect by simple DNA strand break analysis. Chemicals requiring metabolic activation were preincubated with rat liver S9 fraction. TK-6 human lymphoblastoid cells were treated with a range of concentrations of each chemical, above and below the expected cytotoxic concentration. Trials were carried out in 3 centres applying all three formats. Results obtained with the three systems (standard, medium- and high-throughput) were essentially the same. The 96-minigel format was analysed with the fully automated scoring system IMSTAR and comparable results were achieved with the semi-automated scoring system from Perceptives. The known genotoxic chemicals MNU, B(a)P, 4-NQO and cyclophosphamide showed little consistent sign of genotoxicity at concentrations causing limited cytotoxicity. D-mannitol and Triton X-100 were, as expected, non-genotoxic (though Triton X-100, at high concentrations, caused DNA breaks as an apparent secondary effect of cytotoxicity). Etoposide and bleomycin gave significant increase in DNA strand break at borderline cytotoxic concentrations. The limitation of the assay to detect damaged bases by known genotoxins may be overcome by incorporating a DNA repair enzyme, such as formamidopyrimidine-DNA-glycosylase (FPG), to convert damaged bases into breaks as shown by Azqueta A et al., Mutagenesis vol. 28 no. 3 pp. 271–277, 2013 .

Keywords: high throughput, chemicals, Genotoxicity, Repair enzymes, validation trial

Conference: ICAW 2015 - 11th International Comet Assay Workshop, Antwerpen, Belgium, 1 Sep - 4 Sep, 2015.

Presentation Type: Poster Discussion

Topic: New applications and technical improvements

Citation: Gutzkow KB, Azqueta A, Priestley C, Graupner A, Drlickova M, Dusinska M, Brunborg G, Soussaline F and Collins A (2015). A pre-validation trial - testing genotoxicity of several chemicals using standard, medium- and high-throughput comet formats.. Front. Genet. Conference Abstract: ICAW 2015 - 11th International Comet Assay Workshop. doi: 10.3389/conf.fgene.2015.01.00064

Copyright: The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers. They are made available through the Frontiers publishing platform as a service to conference organizers and presenters.

The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated.

Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed.

For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions.

Received: 15 May 2015; Published Online: 23 Jun 2015.

* Correspondence: Dr. Kristine B Gutzkow, Norwegian institute of public health, Environmental medicine, Oslo, 0456, Norway, kristinebjerve.gutzkow@fhi.no